Europe Contract Research Organization Market size is projected to reach US$ 40,023.68 million by 2031 from US$ 22,885.00 million in 2024. The market is estimated to register a CAGR of 8.3% during 2024–2031. The increased outsourcing of R&D and sustainability initiatives is likely to bring new trends to the market in the coming years.
Europe Contract Research Organization Market Analysis
The Contract Research Organization (CRO) market in Europe is expanding as more pharmaceutical and biotech companies choose to outsource their research and development (R&D). Developing new drugs is a long, complex, and costly process, and CROs help ease that burden by managing clinical trials, handling regulatory paperwork, and analyzing data. This allows companies to focus on innovation while experts take care of the technical and compliance-heavy aspects. The regulatory landscape of Europe is complex, and each country has its own set of rules, making it challenging for companies to navigate approvals alone. CROs bring the expertise needed to streamline this process, saving time and resources. At the same time, advancements in technology, such as AI-driven analytics and digital trial management, are making research faster and more efficient. Countries such as Germany, France, and the UK are leading the way in clinical research, with strong healthcare systems supporting growth. While concerns around data security and intellectual property exist, the benefits—cost savings, faster market access, and specialized knowledge—far outweigh the risks. As the pharmaceutical industry evolves, CROs are anticipated to continue playing a crucial role in bringing life-changing treatments to patients more quickly and efficiently.
Europe Contract Research Organization Market Overview
The Contract Research Organization (CRO) industry is growing strongly in Europe, owing to rising outsourcing of research and development (R&D) operations in pharmaceutical, biotechnology, and medical device firms. With the healthcare sector becoming increasingly competitive and innovative, firms are under pressure to speed up drug discovery. Contracting R&D to CROs enables companies to access their specialized expertise, sophisticated infrastructure, and global connectivity without significant investments. CROs offer full-service solutions, from preclinical research to clinical trials, regulatory affairs, and post-marketing surveillance, and thus help sponsors concentrate on their core competencies. In addition, the increasing complexity of clinical trials due to the commonality of chronic diseases, orphan diseases, and personalized medicine has raised the demand for niche CROs with specialized knowledge and technological capacities.
In Europe, tightly regulated regimes such as the EU Clinical Trials Regulation (CTR) have encouraged businesses to utilize CROs since they simplify compliance procedures and have extensive familiarity with local regulatory environments. Small and medium-sized enterprises (SMEs), with their limited ability to carry out in-house R&D, increasingly use CROs' services because of their low-cost offerings and availability of cutting-edge technology such as AI-powered data analysis and decentralized clinical trials. CROs can manage multinational trials and make patients with diverse demographics available, which are imperative for obtaining regulatory approvals and ensuring market growth. In addition, the advent of biologics, biosimilars, and cell and gene therapies has introduced a demand for expert R&D services that many CROs are well-positioned to provide. This outsourcing alleviates operational pressures for sponsors and drives innovation by facilitating partnerships between CROs and academic centers, startups, and technology companies. Consequently, the market is well positioned for continued growth due to rising dependence on R&D outsourcing to achieve efficiency, save costs, and get life-saving drugs to patients more quickly.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Europe Contract Research Organization Market: Strategic Insights
Market Size Value in US$ 12,476.8 Million in 2017 Market Size Value by US$ 22,157.62 Million in 2025 Growth rate CAGR of 7.7% from 2018-2025 Forecast Period 2018-2025 Base Year 2018
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Europe Contract Research Organization Market: Strategic Insights
| Market Size Value in | US$ 12,476.8 Million in 2017 |
| Market Size Value by | US$ 22,157.62 Million in 2025 |
| Growth rate | CAGR of 7.7% from 2018-2025 |
| Forecast Period | 2018-2025 |
| Base Year | 2018 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Europe Contract Research Organization Market Drivers and Opportunities
Rising Demand for Clinical Trials Bolsters Market Growth
Europe is the global leader in healthcare innovation and has seen a surge in clinical trials due to its diverse patient population, advanced healthcare infrastructure, and strong regulatory framework. The need for faster drug development and approval timelines fuels the reliance on CROs to execute clinical trials efficiently. According to the European Medicines Agency 2021, The EU Clinical Trials Register displays 44,302 clinical trials with an EudraCT protocol, of which 7,355 are clinical trials conducted with subjects under 18 years old. According to the Association of the British Pharmaceutical Industry (ABPI), the clinical trials increased by 4.3% per year, from 394 trials in 2021 to 411 in 2022. Further, the UK government provides funding to encourage clinical trials. For instance, in August 2024, the UK secured a US$ 445.35 million investment by the UK government to boost clinical trials. The investments are expected to support faster patient access to cutting-edge treatments, strengthen clinical trials, and improve medicines manufacturing in the UK.
Sponsors tend to outsource these trials to CROs to access their specialized skill sets, exposure to innovative technologies, and established networks for trial management and patient recruitment. In Europe, the introduction of the EU Clinical Trials Regulation (CTR) has centralized the clinical trial application procedure in all the member states, making it an attractive place for sponsors from other parts of the world. CROs become invaluable resources for handling such regulatory needs, compliance, and minimizing administrative burdens for the sponsors.
In 2021, Europe hosted the highest proportion of clinical trials worldwide, with Germany, the UK, France, and Spain proving to be primary centers based on the strength of their healthcare infrastructures and conducive regulatory landscapes. Small and medium-sized enterprises (SMEs) increasingly resorted to the cost-saving offerings of CROs while frequently pioneering innovation with having limited funds for running in-house clinical trials. Increased demand for clinical trials has also been fueled by the expanding pipeline of new drugs, especially in oncology, immunology, and neurology, where clinical trials are essential to prove efficacy and safety. CROs offer full-service support, from protocol development and patient enrollment to data analysis and reporting, allowing sponsors to concentrate on their core strengths while guaranteeing high-quality trial execution.
Expansion of Biologics and Biosimilars to Create Growth Opportunities
The growth potential for the CRO market is largely supplemented with the upcoming biologics and biosimilars, mainly due to the increased competition from innovative therapies and the expired patents of blockbuster biologics. Biologics include product types such as monoclonal antibodies and recombinant proteins, and these will rule the landscape of biopharmaceuticals mainly owing to their strengths in curing chronic and life-threatening diseases. With patent expiration for most biologics, the market for biosimilars, copies of biologics that are very similar and price-effective, is already developing rapidly. CROs are expected to gain lucratively in outsourcing research and development for the faster delivery of biosimilars.
The high cost and lengthy process of developing biologics attract outsourcing to CROs, with companies looking to cost cutting and shorten time-to-market. CROs investing in advanced technologies, biologics, and biosimilar expertise should expect to profit most from this expanding pool. The world's push for financially affordable health solutions continues to fuel this growth, with the cost savings generated by biosimilars that are therapeutically equivalent to their reference biologics. Therefore, the continuous increase in biologics and biosimilars is exciting the market and stressing the importance of CROs in advancing biopharmaceutical development and helping to meet unmet medical needs.
Europe Contract Research Organization Market Report Segmentation Analysis
Key segments that contributed to the derivation of the Europe Contract Research Organization Market analysis are Service Type, Product Type, Type, Application, End User, and Country.
Based on service type, the Europe contract research organization market is segmented into early phase development services, clinical research services, laboratory services, and post-approval services. The Clinical Research Services segment held the largest share of the Europe Contract Research Organization Market in 2024, and it is expected to register a significant CAGR during 2024–2031.
By Product type, the market is segmented into cell and gene therapy, biosimilars, antibody drug conjugates, and others. The Biosimilars segment held the largest share of the Europe contract research organization market in 2024.
In terms of type, the Europe contract research organization market is bifurcated into in-house and outsource. The outsource segment held a larger share of the Europe contract research organization market in 2024.
Based on application, the market is segmented into oncology, neurology, cardiology, infectious diseases, metabolic disorders, nephrology, respiratory, dermatology, ophthalmology, hematology, and others. The oncology segment held the largest share of the Europe contract research organization market in 2024.
By end user, the Europe contract research organization market is divided into pharmaceutical and biotech companies, medical device companies, and academic and research institutes. The pharmaceutical and biotech companies segment held the largest share of the Europe contract research organization market in 2024.
Europe Contract Research Organization Market Share Analysis by Geography
The geographic scope of the Europe contract research organization market report is mainly divided into seven major countries: The United Kingdom, Germany, France, Italy, Spain, Netherlands, Greece, and the Rest of Europe.
The market growth trajectory is determined by a surge in clinical trials and a rise in demand for outsourced drug discovery services. According to the Association of the British Pharmaceutical Industry (ABPI), the total number of clinical trials increased by 4.3% per year, from 394 trials in 2021 to 411 in 2022. Further, the UK government encourages clinical trials by funding. For instance, in August 2024, the Voluntary Scheme for Branded Medicine Pricing, Access and Growth (VPAG) Investment Programme was launched by the government of the UK. The government announced that NHS patients will benefit from earlier access to new treatments as the UK government launches a US$ 445.35 million (£400 million) public-private investment program. This initiative aims to enhance clinical trials, improve medicine manufacturing, and establish 18 new clinical trial hubs across the UK to accelerate research.
Technological advancements such as AI technologies in France contribute to the growing demand for Contract Research Organizations. CROs in France are increasingly adopting advanced technologies to improve the efficiency and quality of clinical trials. For instance, ICTA, a full-service international CRO, uses an integrated IT platform called I-SIT to manage clinical trials, ensuring secure and efficient data handling throughout the study process.
The changing regulatory environment for clinical trials in France is also positively influencing the market. In August 2024, France introduced the Convention Unique, which includes updated templates for clinical trial agreements. These changes aim to standardize and simplify the initiation of clinical trials by providing standardized clauses for equipment and biological resources. While intended to streamline processes, these updates may also impact the overall budget due to changes in the cost of research. CROs in France play a crucial role in the pharmaceutical and biotechnology sectors by providing a wide range of services to support clinical trials and research initiatives. The surging number of clinical trials and supportive regulatory environment in the country are significantly creating the demand for CRO services.
Market players are adopting inorganic growth strategies for the development of the CRO services market in France. For instance, in September 2023, 1MED, a specialist CRO providing regulatory and clinical support to medical device companies, acquired Evamed, a CRO based in northwest France, also focused on the medical device market. This acquisition established 1MED's presence in France and strengthened the company's capabilities in high-complexity interventional trials with higher-risk devices.
Europe Contract Research Organization Market Report Scope
Europe Contract Research Organization Market News and Recent Developments
Europe Contract Research Organization Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the market are listed below:
- Thermo Fisher Scientific launched the International CorEvitas Clinical Registry in Adolescent Alopecia Areata. The registry was made active in both Europe and the US. The first patient was enrolled in Europe. This marked the 12th independent registry from CorEvitas, which was part of the PPD clinical research division of Thermo Fisher Scientific. It complemented an existing CorEvitas registry that focused on adult AA, launched in 2023.
Thermo Fisher Scientific launched International CorEvitas Clinical Registry in adolescent atopic dermatitis, a chronic skin condition. The registry enrolled its first European Union patient, expanding its geographic footprint of enrollment beyond North America, where the first patient was enrolled in December 2023. The registry addressed a critical unmet need for real-world evidence and adolescent-specific developmental and safety data related to novel therapies for AD, and it complemented the existing adult CorEvitas AD Registry that had been launched in 2020.
Europe Contract Research Organization Market Report Coverage and Deliverables
The " Europe Contract Research Organization Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Europe Contract Research Organization Market size and forecast at regional, and country levels for all the key market segments covered under the scope
- Europe Contract Research Organization Market trends, as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- Europe Contract Research Organization Market analysis covering key market trends, regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Europe Contract Research Organization Market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, End User, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
UK, Germany, France, Italy, Russia
Frequently Asked Questions
Rising demand for clinical trials and growing outsourcing of R&D are among the significant factors fueling the market growth.
The UK dominated the market in 2024.
Parexel International Corp, Thermo Fisher Scientific (PPD Inc), Precision Medicine Group, LLC, ProPharma Group, Medpace Holdings Inc, O4 Research Ltd, Julius Clinical, Siron Clinical, Clinmark sp. z o.o., Pharmaxi LL are among the prominent players operating in the market.
The adoption of advanced technologies in clinical research and sustainability initiatives is expected to emerge as a prime trend in the market during the forecast period.
The market is expected to register a CAGR of 8.3% during 2024–2031.
The market value is expected to reach US$ 40,023.68 million by 2031.
1. Introduction 17
1.1 The Insight Partners Research Report Guidance. 17
1.2 Market Segmentation. 18
2. Executive Summary 19
2.1 Key Insights. 19
3. Research Methodology 20
3.1 Secondary Research. 21
3.2 Primary Research. 21
3.2.1 Hypothesis formulation: 21
3.2.2 Macro-economic factor analysis: 22
3.2.3 Developing base number: 22
3.2.4 Data Triangulation: 22
3.2.5 Country level data: 22
4. Europe Contract Research Organization (CRO) Market Landscape 23
4.1 Overview. 23
4.2 PEST Analysis. 23
5. Europe Contract Research Organization (CRO) Market – Key Market Dynamics 24
5.1 Europe Contract Research Organization (CRO) Market – Key Market Dynamics. 24
5.2 Market Drivers. 24
5.2.1 Increased Outsourcing of R&D. 24
5.2.2 Rising Demand for Clinical Trials. 25
5.3 Market Restraints. 25
5.3.1 High Competition Among CROs. 25
5.4 Market Opportunities. 26
5.4.1 Expansion of Biologics and Biosimilars. 26
5.5 Future Trends. 26
5.5.1 Sustainability Initiatives. 26
5.6 Impact of Drivers and Restraints: 27
6. Europe Contract Research Organization (CRO) Market Analysis 28
6.1 Europe Contract Research Organization (CRO) Market Revenue (US$ Million), 2021–2031. 28
6.2 Europe Contract Research Organization (CRO) Market Forecast and Analysis. 28
7. Europe Contract Research Organization (CRO) Market Analysis – by Service Type 29
7.1 Early Phase Development Services. 30
7.1.1 Overview. 30
7.1.2 Early Phase Development Services: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 30
7.2 Clinical Research Services. 31
7.2.1 Overview. 31
7.2.2 Clinical Research Services: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 32
7.3 Laboratory Services. 32
7.3.1 Overview. 32
7.3.2 Laboratory Services: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 33
7.4 Post-Approval Services. 33
7.4.1 Overview. 33
7.4.2 Post-Approval Services: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 34
8. Europe Contract Research Organization (CRO) Market Analysis – by Product Type 35
8.1 Cell and Gene Therapy. 36
8.1.1 Overview. 36
8.1.2 Cell and Gene Therapy: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 36
8.2 Biosimilars. 37
8.2.1 Overview. 37
8.2.2 Biosimilars: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 37
8.3 Antibody Drug Conjugates. 38
8.3.1 Overview. 38
8.3.2 Antibody Drug Conjugates: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 38
8.4 Others. 39
8.4.1 Overview. 39
8.4.2 Others: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 39
9. Europe Contract Research Organization (CRO) Market Analysis – by Type 40
9.1 In-house. 41
9.1.1 Overview. 41
9.1.2 In-house: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 41
9.2 Outsource. 42
9.2.1 Overview. 42
9.2.2 Outsource: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 42
10. Europe Contract Research Organization (CRO) Market Analysis – by Application 43
10.1 Oncology. 45
10.1.1 Overview. 45
10.1.2 Oncology: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 45
10.2 Neurology. 46
10.2.1 Overview. 46
10.2.2 Neurology: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 46
10.3 Cardiology. 47
10.3.1 Overview. 47
10.3.2 Cardiology: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 47
10.4 Infectious Diseases. 48
10.4.1 Overview. 48
10.4.2 Infectious Diseases: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 48
10.5 Metabolic Disorder 49
10.5.1 Overview. 49
10.5.2 Metabolic Disorder: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 49
10.6 Nephrology. 50
10.6.1 Overview. 50
10.6.2 Nephrology: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 50
10.7 Respiratory. 51
10.7.1 Overview. 51
10.7.2 Respiratory: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 51
10.8 Dermatology. 52
10.8.1 Overview. 52
10.8.2 Dermatology: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 52
10.9 Ophthalmology. 53
10.9.1 Overview. 53
10.9.2 Ophthalmology: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 53
10.10 Hematology. 54
10.10.1 Overview. 54
10.10.2 Hematology: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 54
10.11 Others. 55
10.11.1 Overview. 55
10.11.2 Others: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 55
11. Europe Contract Research Organization (CRO) Market Analysis – by End User 56
11.1 Pharmaceutical and Biotech Companies. 57
11.1.1 Overview. 57
11.1.2 Pharmaceutical and Biotech Companies: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 57
11.2 Medical Device Companies. 58
11.2.1 Overview. 58
11.2.2 Medical Device Companies: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 58
11.3 Academic and Research Institutes. 59
11.3.1 Overview. 59
11.3.2 Academic and Research Institutes: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 59
11.4 Others. 60
11.4.1 Overview. 60
11.4.2 Others: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 60
12. Europe Contract Research Organization (CRO) Market – Country Analysis 61
12.1 Europe. 61
12.1.1 Europe Contract Research Organization (CRO) Market Breakdown by Countries. 61
12.1.2 Europe Contract Research Organization (CRO) Market Revenue and Forecast and Analysis – by Country. 61
12.1.2.1 Europe Contract Research Organization (CRO) Market Revenue and Forecast and Analysis – by Country. 62
12.1.2.2 United Kingdom: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 62
12.1.2.2.1 United Kingdom: Europe Contract Research Organization (CRO) Market Breakdown by Service Type. 63
12.1.2.2.2 United Kingdom: Europe Contract Research Organization (CRO) Market Breakdown by Product type. 64
12.1.2.2.3 United Kingdom: Europe Contract Research Organization (CRO) Market Breakdown by Type. 64
12.1.2.2.4 United Kingdom: Europe Contract Research Organization (CRO) Market Breakdown by Application. 65
12.1.2.2.5 United Kingdom: Europe Contract Research Organization (CRO) Market Breakdown by End User 65
12.1.2.3 Germany: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 66
12.1.2.3.1 Germany: Europe Contract Research Organization (CRO) Market Breakdown by Service Type. 67
12.1.2.3.2 Germany: Europe Contract Research Organization (CRO) Market Breakdown by Product type. 67
12.1.2.3.3 Germany: Europe Contract Research Organization (CRO) Market Breakdown by Type. 67
12.1.2.3.4 Germany: Europe Contract Research Organization (CRO) Market Breakdown by Application. 68
12.1.2.3.5 Germany: Europe Contract Research Organization (CRO) Market Breakdown by End User 68
12.1.2.4 France: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 69
12.1.2.4.1 France: Europe Contract Research Organization (CRO) Market Breakdown by Service Type. 70
12.1.2.4.2 France: Europe Contract Research Organization (CRO) Market Breakdown by Product type. 70
12.1.2.4.3 France: Europe Contract Research Organization (CRO) Market Breakdown by Type. 70
12.1.2.4.4 France: Europe Contract Research Organization (CRO) Market Breakdown by Application. 71
12.1.2.4.5 France: Europe Contract Research Organization (CRO) Market Breakdown by End User 71
12.1.2.5 Italy: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 72
12.1.2.5.1 Italy: Europe Contract Research Organization (CRO) Market Breakdown by Service Type. 73
12.1.2.5.2 Italy: Europe Contract Research Organization (CRO) Market Breakdown by Product type. 73
12.1.2.5.3 Italy: Europe Contract Research Organization (CRO) Market Breakdown by Type. 73
12.1.2.5.4 Italy: Europe Contract Research Organization (CRO) Market Breakdown by Application. 74
12.1.2.5.5 Italy: Europe Contract Research Organization (CRO) Market Breakdown by End User 74
12.1.2.6 Spain: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 75
12.1.2.6.1 Spain: Europe Contract Research Organization (CRO) Market Breakdown by Service Type. 76
12.1.2.6.2 Spain: Europe Contract Research Organization (CRO) Market Breakdown by Product type. 76
12.1.2.6.3 Spain: Europe Contract Research Organization (CRO) Market Breakdown by Type. 76
12.1.2.6.4 Spain: Europe Contract Research Organization (CRO) Market Breakdown by Application. 77
12.1.2.6.5 Spain: Europe Contract Research Organization (CRO) Market Breakdown by End User 77
12.1.2.7 Netherlands: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 78
12.1.2.7.1 Netherlands: Europe Contract Research Organization (CRO) Market Breakdown by Service Type. 79
12.1.2.7.2 Netherlands: Europe Contract Research Organization (CRO) Market Breakdown by Product type. 79
12.1.2.7.3 Netherlands: Europe Contract Research Organization (CRO) Market Breakdown by Type. 79
12.1.2.7.4 Netherlands: Europe Contract Research Organization (CRO) Market Breakdown by Application. 80
12.1.2.7.5 Netherlands: Europe Contract Research Organization (CRO) Market Breakdown by End User 80
12.1.2.8 Greece: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 81
12.1.2.8.1 Greece: Europe Contract Research Organization (CRO) Market Breakdown by Service Type. 82
12.1.2.8.2 Greece: Europe Contract Research Organization (CRO) Market Breakdown by Product type. 82
12.1.2.8.3 Greece: Europe Contract Research Organization (CRO) Market Breakdown by Type. 83
12.1.2.8.4 Greece: Europe Contract Research Organization (CRO) Market Breakdown by Application. 83
12.1.2.8.5 Greece: Europe Contract Research Organization (CRO) Market Breakdown by End User 84
12.1.2.9 Rest of Europe: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 85
12.1.2.9.1 Rest of Europe: Europe Contract Research Organization (CRO) Market Breakdown by Service Type. 86
12.1.2.9.2 Rest of Europe: Europe Contract Research Organization (CRO) Market Breakdown by Product type. 86
12.1.2.9.3 Rest of Europe: Europe Contract Research Organization (CRO) Market Breakdown by Type. 86
12.1.2.9.4 Rest of Europe: Europe Contract Research Organization (CRO) Market Breakdown by Application. 87
12.1.2.9.5 Rest of Europe: Europe Contract Research Organization (CRO) Market Breakdown by End User 87
13. Industry Landscape 88
13.1 Overview. 88
13.2 Expansion. 88
13.3 New Product Development 88
13.4 Merger and Acquisition. 88
14. Company Profiles 89
14.1 Parexel International Corp. 89
14.1.1 Key Facts. 89
14.1.2 Business Description. 89
14.1.3 Products and Services. 89
14.1.4 Financial Overview. 91
14.1.5 SWOT Analysis. 91
14.1.6 Key Developments. 92
14.2 Thermo Fisher Scientific (PPD Inc) 93
14.2.1 Key Facts. 93
14.2.2 Business Description. 93
14.2.3 Products and Services. 93
14.2.4 Financial Overview. 94
14.2.5 SWOT Analysis. 95
14.2.6 Key Developments. 97
14.3 Precision Medicine Group, LLC. 99
14.3.1 Key Facts. 99
14.3.2 Business Description. 99
14.3.3 Products and Services. 99
14.3.4 Financial Overview. 99
14.3.5 SWOT Analysis. 99
14.3.6 Key Developments. 100
14.4 ProPharma Group. 101
14.4.1 Key Facts. 101
14.4.2 Business Description. 101
14.4.3 Products and Services. 101
14.4.4 Financial Overview. 101
14.4.5 SWOT Analysis. 102
14.4.6 Key Developments. 102
14.5 Medpace Holdings Inc. 103
14.5.1 Key Facts. 103
14.5.2 Business Description. 103
14.5.3 Products and Services. 103
14.5.4 Financial Overview. 104
14.5.5 SWOT Analysis. 104
14.5.6 Key Developments. 105
14.6 O4 Research Ltd. 106
14.6.1 Key Facts. 106
14.6.2 Business Description. 106
14.6.3 Products and Services. 106
14.6.4 Financial Overview. 107
14.6.5 SWOT Analysis. 107
14.6.6 Key Developments. 108
14.7 Julius Clinical 109
14.7.1 Key Facts. 109
14.7.2 Business Description. 109
14.7.3 Products and Services. 109
14.7.4 Financial Overview. 110
14.7.5 SWOT Analysis. 110
14.7.6 Key Developments. 111
14.8 Siron Clinical 112
14.8.1 Key Facts. 112
14.8.2 Business Description. 112
14.8.3 Products and Services. 112
14.8.4 Financial Overview. 113
14.8.5 SWOT Analysis. 113
14.8.6 Key Developments. 114
14.9 Clinmark sp. z o.o. 115
14.9.1 Key Facts. 115
14.9.2 Business Description. 115
14.9.3 Products and Services. 115
14.9.4 Financial Overview. 116
14.9.5 SWOT Analysis. 116
14.9.6 Key Developments. 117
14.10 Pharmaxi LLC. 118
14.10.1 Key Facts. 118
14.10.2 Business Description. 118
14.10.3 Products and Services. 118
14.10.4 Financial Overview. 118
14.10.5 SWOT Analysis. 119
14.10.6 Key Developments. 119
14.11 AURIGON GMBH. 120
14.11.1 Key Facts. 120
14.11.2 Business Description. 120
14.11.3 Products and Services. 120
14.11.4 Financial Overview. 120
14.11.5 SWOT Analysis. 121
14.11.6 Key Developments. 122
14.12 Smerud Medical Research Group. 123
14.12.1 Key Facts. 123
14.12.2 Business Description. 123
14.12.3 Products and Services. 123
14.12.4 Financial Overview. 124
14.12.5 SWOT Analysis. 125
14.12.6 Key Developments. 126
15. Appendix 127
15.1 Glossary of Terms. 127
15.2 About The Insight Partners. 129
List of Tables
Table 1. Europe Contract Research Organization (CRO) Market Segmentation. 18
Table 2. Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 28
Table 3. Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Service Type. 29
Table 4. Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type. 35
Table 5. Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Type. 40
Table 6. Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Application. 44
Table 7. Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by End User 56
Table 8. Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Country. 62
Table 9. United Kingdom: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Service Type. 63
Table 10. United Kingdom: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Product type. 64
Table 11. United Kingdom: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Type. 64
Table 12. United Kingdom: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Application. 65
Table 13. United Kingdom: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by End User 65
Table 14. Germany: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Service Type. 67
Table 15. Germany: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Product type. 67
Table 16. Germany: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Type. 67
Table 17. Germany: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Application. 68
Table 18. Germany: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by End User 68
Table 19. France: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Service Type. 70
Table 20. France: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Product type. 70
Table 21. France: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Type. 70
Table 22. France: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Application. 71
Table 23. France: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by End User 71
Table 24. Italy: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Service Type. 73
Table 25. Italy: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Product type. 73
Table 26. Italy: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Type. 73
Table 27. Italy: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Application. 74
Table 28. Italy: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by End User 74
Table 29. Spain: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Service Type. 76
Table 30. Spain: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Product type. 76
Table 31. Spain: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Type. 76
Table 32. Spain: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Application. 77
Table 33. Spain: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by End User 77
Table 34. Netherlands: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Service Type. 79
Table 35. Netherlands: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Product type. 79
Table 36. Netherlands: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Type. 79
Table 37. Netherlands: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Application. 80
Table 38. Netherlands: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by End User 80
Table 39. Greece: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Service Type. 82
Table 40. Greece: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Product type. 82
Table 41. Greece: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Type. 83
Table 42. Greece: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Application. 83
Table 43. Greece: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by End User 84
Table 44. Rest of Europe: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Service Type. 86
Table 45. Rest of Europe: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Product type. 86
Table 46. Rest of Europe: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Type. 86
Table 47. Rest of Europe: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by Application. 87
Table 48. Rest of Europe: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) – by End User 87
Table 49. Glossary of Terms, Europe Contract Research Organization (CRO) Market 127
List of Figures
Figure 1. Europe Contract Research Organization (CRO) Market Segmentation, by Country. 18
Figure 2. PEST Analysis. 23
Figure 3. Impact Analysis of Drivers and Restraints. 27
Figure 4. Europe Contract Research Organization (CRO) Market Revenue (US$ Million), 2021–2031. 28
Figure 5. Europe Contract Research Organization (CRO) Market Share (%) – by Service Type, 2024 and 2031. 29
Figure 6. Early Phase Development Services: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 30
Figure 7. Clinical Research Services: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 32
Figure 8. Laboratory Services: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 33
Figure 9. Post-Approval Services: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 34
Figure 10. Europe Contract Research Organization (CRO) Market Share (%) – by Product type, 2024 and 2031. 35
Figure 11. Cell and Gene Therapy: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 36
Figure 12. Biosimilars: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 37
Figure 13. Antibody Drug Conjugates: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 38
Figure 14. Others: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 39
Figure 15. Europe Contract Research Organization (CRO) Market Share (%) – by Type, 2024 and 2031. 40
Figure 16. In-house: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 41
Figure 17. Outsource: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 42
Figure 18. Europe Contract Research Organization (CRO) Market Share (%) – by Application, 2024 and 2031. 43
Figure 19. Oncology: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 45
Figure 20. Neurology: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 46
Figure 21. Cardiology: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 47
Figure 22. Infectious Diseases: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 48
Figure 23. Metabolic Disorder: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 49
Figure 24. Nephrology: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 50
Figure 25. Respiratory: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 51
Figure 26. Dermatology: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 52
Figure 27. Ophthalmology: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 53
Figure 28. Hematology: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 54
Figure 29. Others: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 55
Figure 30. Europe Contract Research Organization (CRO) Market Share (%) – by End User, 2024 and 2031. 56
Figure 31. Pharmaceutical and Biotech Companies: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 57
Figure 32. Medical Device Companies: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 58
Figure 33. Academic and Research Institutes: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 59
Figure 34. Others: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 60
Figure 35. Europe Contract Research Organization (CRO) Market Breakdown by Key Countries, 2024 and 2031 (%) 61
Figure 36. United Kingdom: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 62
Figure 37. Germany: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 66
Figure 38. France: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 69
Figure 39. Italy: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 72
Figure 40. Spain: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 75
Figure 41. Netherlands: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 78
Figure 42. Greece: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 81
Figure 43. Rest of Europe: Europe Contract Research Organization (CRO) Market – Revenue and Forecast to 2031 (US$ Million) 85
The List of Companies - Europe Contract Research Organization (CRO) Market
- Smerud Medical Research Group
- AURIGON GMBH,
- Pharmaxi LLC,
- Clinmark sp. z o.o,
- Siron Clinical,
- Julius Clinical,
- O4 Research Ltd,
- Medpace Holdings Inc,
- ProPharma Group,
- Precision Medicine Group, LLC,
- Thermo Fisher Scientific (PPD Inc),
- Parexel International Corp.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For